Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15017 total
DELL enters the final stretch before June 25 earnings having done something rare in a single week: it rendered its entire prior analyst consensus obsolete, repriced 43% higher, and then immediately gave back 6.6% in a…
Ardent Health enters June trading against a sector-wide downdraft — hospital peers fell hard last week — but the stock itself stayed relatively anchored, down just 0.2% on the week while close comparables like UHS and…
Ares Management Corporation enters its June 8 earnings call with short sellers adding positions at the fastest pace in months, even as the stock has recovered sharply from its spring lows. The clearest short-side…
Ondas Inc. has gained 39% on the week, shorts have begun to cover, and the borrow market has cracked open — but the CEO just sold $32 million worth of stock at the top. The most important development since yesterday's…
Arvinas heads into its June 24 earnings with the stock down 24% over the past month and defensive positioning in the options market at its most extreme level of the year. The clearest tension this week is between what…
NIO heads into its June 4 earnings print with a 14% weekly rally on the board and a short position that has barely flinched. The price recovery is real but context matters. NIO closed at $6.01, up 14.3% on the week — a…
Elanco Animal Health heads into the first week of June with a striking contradiction: short sellers have rebuilt positions aggressively while the company's own CEO put fresh money to work at the lows. Short interest…
Bloom Energy heads into June with its post-earnings stock price holding near $303 — but the two most pointed signals in the data are both pointing the same way: shorts are rebuilding positions, and insiders are still…
XLC, the Communication Services Select Sector SPDR ETF, enters June with short sellers meaningfully pulling back — just as the price itself wobbles and AT&T, one of its top holdings, slides on fresh selling…
KKR enters the first week of June with a curious split: every insider who bought the stock near these levels in February and March is sitting on a small loss, yet short sellers are only just beginning to show up in any…
Construction Partners enters June with fresh analyst coverage and a stock under pressure — a combination that sets up an interesting read on where conviction actually sits. The week's standout event arrived this…
Bit Digital dropped 6% on Tuesday to close at $1.98, giving back gains after a month that still delivered a 26% return. The week's tension is straightforward: a persistent short position near its six-week high is…
AVGO delivered its Q2 earnings on June 3 and the market's verdict was swift — the stock closed at $481.57, up 4.7% on the day and 14% on the week, breaking cleanly above the analyst target cluster that had been framing…
Arcus Biosciences enters the stretch before its June 11 earnings report carrying two conflicting signals: a fresh clinical collaboration with Bristol Myers Squibb that validates its HIF-2α inhibitor, casdatifan, and a…
Solid Biosciences heads into its June 10 earnings report with an unusual split: short interest climbing while the Street grows more bullish. The earnings event is the lens through which everything else reads this week.…
Vir Biotechnology heads into the first week of June with a deteriorating price chart, rising short interest, and one bullish analyst move that hasn't stopped the stock from falling — a gap worth examining closely. The…
SMPL heads into its next earnings print with short sellers at their most aggressive in months, analyst conviction evaporating, and options traders positioned firmly for further pain. The shift in short positioning is…
Celcuity enters the week after one of its sharpest single-week drops in recent memory — down 32% in five sessions and 26% on Tuesday alone, closing at $91.42. The move puts the stock more than 37% below its one-month…
Ingersoll Rand heads into its June 11 earnings release with analyst conviction fading, short interest climbing, and the stock down 8% in a month — a setup that puts real pressure on the print to stabilise the…
UroGen Pharma heads into its June 22 earnings report with a stock that has lost nearly 10% on the week — yet short sellers have been quietly covering rather than pressing their bets. The week's central tension is that…
